LALPATHLAB Stock Overview
Operates laboratories for carrying out pathological investigations in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Dr. Lal PathLabs Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹3,026.10 |
| 52 Week High | ₹3,653.95 |
| 52 Week Low | ₹1,943.70 |
| Beta | 0.30 |
| 11 Month Change | -8.57% |
| 3 Month Change | -8.41% |
| 1 Year Change | 15.95% |
| 33 Year Change | -11.61% |
| 5 Year Change | 90.46% |
| Change since IPO | 266.80% |
Recent News & Updates
Analysts Are Updating Their Dr. Lal PathLabs Limited (NSE:LALPATHLAB) Estimates After Its Second-Quarter Results
Oct 26
Capital Investment Trends At Dr. Lal PathLabs (NSE:LALPATHLAB) Look Strong
Oct 24Recent updates
Analysts Are Updating Their Dr. Lal PathLabs Limited (NSE:LALPATHLAB) Estimates After Its Second-Quarter Results
Oct 26Capital Investment Trends At Dr. Lal PathLabs (NSE:LALPATHLAB) Look Strong
Oct 24Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Share Price Could Signal Some Risk
Oct 06These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely
Jul 28We Think Dr. Lal PathLabs' (NSE:LALPATHLAB) Profit Is Only A Baseline For What They Can Achieve
May 21What Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) P/E Is Not Telling You
May 01Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital
Apr 13These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Safely
Mar 06Dr. Lal PathLabs Limited Just Missed EPS By 5.4%: Here's What Analysts Think Will Happen Next
Feb 04Subdued Growth No Barrier To Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Price
Dec 28Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?
Nov 17Dr. Lal PathLabs (NSE:LALPATHLAB) Will Be Hoping To Turn Its Returns On Capital Around
Oct 12Here's Why Dr. Lal PathLabs (NSE:LALPATHLAB) Can Manage Its Debt Responsibly
Jul 07Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital
Jun 10Dr. Lal PathLabs (NSE:LALPATHLAB) Could Be Struggling To Allocate Capital
Feb 13Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?
Dec 29Dr. Lal PathLabs (NSE:LALPATHLAB) Will Want To Turn Around Its Return Trends
Sep 21These 4 Measures Indicate That Dr. Lal PathLabs (NSE:LALPATHLAB) Is Using Debt Reasonably Well
Sep 01Dr. Lal PathLabs (NSE:LALPATHLAB) Will Pay A Dividend Of ₹6.00
Jul 31Be Wary Of Dr. Lal PathLabs (NSE:LALPATHLAB) And Its Returns On Capital
Jun 23Does This Valuation Of Dr. Lal PathLabs Limited (NSE:LALPATHLAB) Imply Investors Are Overpaying?
Jun 11Shareholder Returns
| LALPATHLAB | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | 2.4% | 0.8% | 0.3% |
| 1Y | 16.0% | 36.4% | 27.3% |
Return vs Industry: LALPATHLAB underperformed the Indian Healthcare industry which returned 36.4% over the past year.
Return vs Market: LALPATHLAB underperformed the Indian Market which returned 27.3% over the past year.
Price Volatility
| LALPATHLAB volatility | |
|---|---|
| LALPATHLAB Average Weekly Movement | 3.5% |
| Healthcare Industry Average Movement | 5.5% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: LALPATHLAB has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: LALPATHLAB's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1949 | 4,099 | Shankha Banerjee | www.lalpathlabs.com |
Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers training programs.
Dr. Lal PathLabs Limited Fundamentals Summary
| LALPATHLAB fundamental statistics | |
|---|---|
| Market cap | ₹253.40b |
| Earnings (TTM) | ₹4.01b |
| Revenue (TTM) | ₹23.46b |
62.8x
P/E Ratio10.7x
P/S RatioIs LALPATHLAB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LALPATHLAB income statement (TTM) | |
|---|---|
| Revenue | ₹23.46b |
| Cost of Revenue | ₹9.89b |
| Gross Profit | ₹13.57b |
| Other Expenses | ₹9.56b |
| Earnings | ₹4.01b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 48.18 |
| Gross Margin | 57.84% |
| Net Profit Margin | 17.11% |
| Debt/Equity Ratio | 2.0% |
How did LALPATHLAB perform over the long term?
See historical performance and comparisonDividends
0.6%
Current Dividend Yield62%
Payout RatioDoes LALPATHLAB pay a reliable dividends?
See LALPATHLAB dividend history and benchmarks| Dr. Lal PathLabs dividend dates | |
|---|---|
| Ex Dividend Date | Nov 05 2024 |
| Dividend Pay Date | Nov 22 2024 |
| Days until Ex dividend | 17 days |
| Days until Dividend pay date | 0 days |
Does LALPATHLAB pay a reliable dividends?
See LALPATHLAB dividend history and benchmarks